Preventice touts validation of VEB-detecting algorithm, launches Cardiac Holter monitor
Preventice Solutions this week touted data from a validation study of proprietary algorithms that are part of its BodyGuardian Heart system designed to detect ventricular ectopic beats, and announced the launch of its BodyGuardian Mini re-usable Holter cardiac monitor.
Results from the study and the launch were announced at the annual meeting of the Heart Rhythm Society in Boston.
In the study, the Minneapolis-based company performed algorithm validation using the MIT-BIH arrhythmia database and real-wold data collected from approximately 2,000 BodyGuardian Heart patients. Results indicated that its classification model had specificity and sensitivity “higher than any previously published fully automated algorithms,” Preventice said.
“In my opinion, clinicians do not always appreciate the difficulty that ambulatory ECG monitoring systems have in accurately differentiating VEBs from normal sinus rhythm. The application of deep learning to large real-world ECG datasets provides a unique opportunity to enhance the diagnostic accuracy of the algorithms in these ECG monitoring devices,” poster author Dr. Suneet Mittal of Valley Medical Group said in a press release
Preventice also announced the launch of its BodyGuardian Mini, which it claims is the smallest reusable long-term Holter device designed for cardiac monitoring. The system allows for up to 14 days of ECG measurements that are transferable to physicians for monitoring.
The system includes a wearable patch that can be moved and reapplied, or replaced during studies. The BodyGuardian Mini is waterproof, and can be placed centrally on the chest, the company said.
“Our vision for the BodyGuardian Heart system has been grounded in transformative advancement of the technology to address patient and physician needs. Innovative thinking is built into every BodyGuardian Mini. It is an example of technology progress that directly enhances patient compliance through ease-of-use and comfort, based on its small size and reusable, waterproof design. For physicians, the Mini is a technological innovation that can achieve up to 14-days of ECG measurements with fast access to an easy-to-read, data-rich report,” CEO Jon Otterstatter said in a prepared statement.
“Remote cardiac monitoring is an important technology used in the diagnosis of cardiac rhythm abnormalities. Recent advances in technology will make these systems easier for patients to use and even more specific in helping physicians gather insights needed to make accurate clinical diagnosis with faster access to the specific, detailed data from patients, while they go about their daily activities,” Dr. Ziad Issa of the Prairie Heart Institute of Illinois said in a press release.